Document is current
Any future updates will be listed below
-
Authors
Szmulewicz, Alejandro G. https://orcid.org/0000-0002-2664-802X
Martínez-Alés, Gonzalo
Logan, Roger
Joober, Ridha
Ferrara, Maria
Kelly, Christian
Fredrikson, Diane
Thorpe, Lorna E.
Conderino, Sarah
Díaz-Caneja, Covadonga M.
Srihari, Vinod
Yatham, Lakshmi N. https://orcid.org/0000-0002-7405-0954
Sarpal, Deepak K.
Shinn, Ann K.
Arango, Celso
Shah, Jai L. https://orcid.org/0000-0002-7549-6990
Öngür, Dost
Hernán, Miguel A.
,
Durning, Peter
Dow, Jacqueline
Cawkwell, Philip
Markovich, Philip
Díaz-Marsá, Marina
Ayuso-Mateos, Jose Luis
Ibáñez, Ángela
Rodríguez-Jiménez, Roberto
Bravo-Ortiz, María-Fé
Baca-García, Enrique
de Diego, Héctor
Iyer, Srividya
Malla, Ashok
Lepage, Martin
Pawliuk, Nicole
Zavaglia, Elissa
Devenyi, Gabriel
-
Funding
Funding for this research was provided by:
Brain and Behavior Research Foundation (YIG 31313)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (P50 MH115846-06)
- License Information
-
More Information
Article History
Received: 29 October 2024
Accepted: 3 March 2025
First Online: 8 April 2025
Competing interests
: D.O. served on the advisory board for Rapport Therapeutics in the past 12 months. C.M.D.-C. has received honoraria from Angelini and Viatris and travel support from Janssen and Angelini. M.A.H. Serves on the advisory board of ADIA Lab. C.A. has been a consultant to or has received honoraria or grants from Abbot, Acadia, Ambrosetti, Angelini, Biogen, BMS, Boehringer, Carnot, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Menarini, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion, Takeda and Teva. L.N.Y. reports consultant/speaker fees from Alkermes, Allergan (currently Abbvie), Intracellular Therapies, LivaNova, Merck, Newron and Sumitomo Pharma and grants from Allergan (now AbbVie), CIHR and Sumitomo Pharma, outside the submitted work, over the past 3 years. He also received grants from Janssen, BMS, Otsuka, Lundbeck, Astra Zeneca and HLS. R.J. served as speaker and member of advisory board committees for Pfizer, Janssen, BMS, Sunovian, Myelin, Otsuka, Lundbeck, shire and Perdue. The other authors declare no competing interests.
: All research complies with the Declaration of Helsinki. The study was approved by the Harvard TH Chan School of Public Health Institutional Review Board (reference number IRB20-1842).
